BTCY (Biotricity) E10: $-2.24 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BTCY Biotricity Inc BTCY
20 GF Score
Price $0.11
GF Value $0.39
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Biotricity E10?

Biotricity BTCY -0.18% 20 E10 is $-2.24 as of Mar. 2026. GuruFocus rates BTCY with a GF Score™ of 20/100 and a GF Value™ of $0.39 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biotricity's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.016. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.24 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-19), Biotricity's current stock price is $0.1128. Biotricity's E10 for the quarter that ended in Mar. 2026 was $-2.24. Biotricity's Shiller PE Ratio of today is .


Biotricity  (OTCPK:BTCY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biotricity E10 Related Terms


Biotricity E10 Historical Data

* Premium members only.

The historical data trend for Biotricity's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotricity E10 Chart

Biotricity Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.22 -2.24

Biotricity Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.22 -2.24 -2.25 -2.24 -2.24

BTCY vs FEED, LUDG, USAQ: E10 Comparison

For the Medical Devices subindustry, Biotricity's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotricity Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotricity's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biotricity's Shiller PE Ratio falls into.


BTCY
20GF Score
Biotricity Inc BTCY
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biotricity E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biotricity's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.016/330.2130*330.2130
=-0.016

Current CPI (Mar. 2026) = 330.2130.

Biotricity Quarterly Data

per share eps CPI Adj_EPS
201606 -0.251 241.018 -0.344
201609 -0.540 241.428 -0.739
201612 -0.540 241.432 -0.739
201703 -0.420 243.801 -0.569
201706 -0.504 244.955 -0.679
201709 -0.288 246.819 -0.385
201712 -0.408 246.524 -0.547
201803 -0.600 249.554 -0.794
201806 -0.456 251.989 -0.598
201809 -0.396 252.439 -0.518
201812 -0.384 251.233 -0.505
201903 -0.306 254.202 -0.397
201906 -0.360 256.143 -0.464
201909 -0.336 256.759 -0.432
201912 -0.396 256.974 -0.509
202003 -0.804 258.115 -1.029
202006 -0.552 257.797 -0.707
202009 -0.510 260.280 -0.647
202012 -0.666 260.474 -0.844
202103 -0.900 264.877 -1.122
202106 -0.906 271.696 -1.101
202109 -1.536 274.310 -1.849
202112 -0.894 278.802 -1.059
202203 -0.666 287.504 -0.765
202206 -0.588 296.311 -0.655
202209 -0.567 296.808 -0.631
202212 -0.546 296.797 -0.607
202303 -0.557 301.836 -0.609
202306 -0.411 305.109 -0.445
202309 -0.441 307.789 -0.473
202312 -0.339 306.746 -0.365
202403 -0.469 312.332 -0.496
202406 -0.490 314.175 -0.515
202409 -0.073 315.301 -0.076
202412 -0.054 315.605 -0.056
202503 -0.057 319.799 -0.059
202506 -0.029 322.561 -0.030
202509 -0.029 324.800 -0.029
202512 -0.042 324.054 -0.043
202603 -0.016 330.213 -0.016

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-2.24 mean?
Biotricity (BTCY) has a E10 of $-2.24 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Biotricity and its competitors.
Is Biotricity's E10 too high?
Biotricity's current E10 is $-2.24. Overall, Biotricity has a GF Score™ of 20/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biotricity's E10 compare to FEED and LUDG?
Biotricity's E10 of $-2.24 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Biotricity and its competitors. Biotricity's current E10 is $-2.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotricity stock overvalued right now?
Based on GuruFocus' analysis, Biotricity (BTCY) is currently considered Possible Value Trap. The stock's GF Value™ is $0.39, compared to a current price of $0.11 — trading 71.1% below its estimated fair value. The current E10 is $-2.24. Biotricity's overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Biotricity (BTCY), the current E10 is $-2.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biotricity (BTCY) Overvalued in 2026?

Based on GuruFocus' analysis, Biotricity stock appears to be undervalued. The current stock price of $0.11 is trading 71.1% below its estimated GF Value™ of $0.39. GuruFocus considers Biotricity to be Possible Value Trap.

Key valuation signals for BTCY:

  • E10: $-2.24
  • GF Value™: $0.39 vs. price of $0.11 (71.1% below fair value)
  • GF Score™: 20/100 with 7 warning signs

No single metric tells the full story. See the BTCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biotricity Business Description

Address 203 Redwood Shores Parkway, Suite 600, Redwood City, CA, USA, 94065
Biotricity Inc is a medical technology company that focuses on biometric data monitoring solutions. It aims to deliver remote monitoring solutions to the healthcare & consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Its products include Bioflux, which is a mobile cardiac telemetry (MCT) device that provides real-time monitoring and transmission of ambulatory patients' ECG information; Biocare Telemed; Bioheart, which is a personal heart monitor; Biokit, and Biocare health.
20GF Score

Get the complete analysis for BTCY

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price
$0.39
GF Value